Annual Working Capital
$3.36 M
-$8.78 M-72.32%
December 31, 2023
Summary
- As of February 20, 2025, AMPE annual working capital is $3.36 million, with the most recent change of -$8.78 million (-72.32%) on December 31, 2023.
- During the last 3 years, AMPE annual working capital has fallen by -$13.30 million (-79.83%).
- AMPE annual working capital is now -92.94% below its all-time high of $47.58 million, reached on December 31, 2014.
Performance
AMPE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$3.36 M
-$2.02 M-37.49%
December 31, 2023
Summary
- As of February 20, 2025, AMPE quarterly working capital is $3.36 million, with the most recent change of -$2.02 million (-37.49%) on December 31, 2023.
- Over the past year, AMPE quarterly working capital has dropped by -$8.78 million (-72.32%).
- AMPE quarterly working capital is now -95.45% below its all-time high of $73.90 million, reached on March 31, 2014.
Performance
AMPE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AMPE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.3% | -72.3% |
| 3 y3 years | -79.8% | -79.8% |
| 5 y5 years | -49.5% | -49.5% |
AMPE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -89.0% | at low | -89.0% | at low |
| 5 y | 5-year | -89.0% | at low | -89.0% | +421.8% |
| alltime | all time | -92.9% | +183.8% | -95.5% | +183.8% |
Ampio Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $3.36 M(-72.3%) | $3.36 M(-37.5%) |
| Sep 2023 | - | $5.38 M(-19.2%) |
| Jun 2023 | - | $6.65 M(-17.5%) |
| Mar 2023 | - | $8.06 M(-33.6%) |
| Dec 2022 | $12.14 M(-60.2%) | $12.14 M(-15.7%) |
| Sep 2022 | - | $14.40 M(-26.4%) |
| Jun 2022 | - | $19.56 M(-19.8%) |
| Mar 2022 | - | $24.38 M(-20.1%) |
| Dec 2021 | $30.51 M(+83.1%) | $30.51 M(+84.0%) |
| Sep 2021 | - | $16.58 M(-15.7%) |
| Jun 2021 | - | $19.67 M(+23.3%) |
| Mar 2021 | - | $15.96 M(-4.2%) |
| Dec 2020 | $16.66 M(+320.0%) | $16.66 M(+86.8%) |
| Sep 2020 | - | $8.92 M(+109.8%) |
| Jun 2020 | - | $4.25 M(-507.1%) |
| Mar 2020 | - | -$1.04 M(-126.3%) |
| Dec 2019 | $3.97 M(-40.3%) | $3.97 M(-47.1%) |
| Sep 2019 | - | $7.50 M(-38.0%) |
| Jun 2019 | - | $12.09 M(+188.3%) |
| Mar 2019 | - | $4.19 M(-36.9%) |
| Dec 2018 | $6.65 M(+45.6%) | $6.65 M(-10.9%) |
| Sep 2018 | - | $7.46 M(+324.6%) |
| Jun 2018 | - | $1.76 M(-59.8%) |
| Mar 2018 | - | $4.37 M(-4.3%) |
| Dec 2017 | $4.56 M(+39.7%) | $4.56 M(<-9900.0%) |
| Sep 2017 | - | -$21.10 K(-100.8%) |
| Jun 2017 | - | $2.49 M(+197.3%) |
| Mar 2017 | - | $838.30 K(-74.3%) |
| Dec 2016 | $3.27 M(-86.2%) | $3.27 M(-44.5%) |
| Sep 2016 | - | $5.89 M(+20.4%) |
| Jun 2016 | - | $4.89 M(-41.6%) |
| Mar 2016 | - | $8.38 M(-64.7%) |
| Dec 2015 | $23.71 M | $23.71 M(-28.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $33.35 M(-4.3%) |
| Jun 2015 | - | $34.86 M(-16.2%) |
| Mar 2015 | - | $41.62 M(-12.5%) |
| Dec 2014 | $47.58 M(+98.5%) | $47.58 M(-13.6%) |
| Sep 2014 | - | $55.06 M(-12.3%) |
| Jun 2014 | - | $62.77 M(-15.1%) |
| Mar 2014 | - | $73.90 M(+208.3%) |
| Dec 2013 | $23.97 M(+47.9%) | $23.97 M(-20.5%) |
| Sep 2013 | - | $30.14 M(+188.7%) |
| Jun 2013 | - | $10.44 M(-31.1%) |
| Mar 2013 | - | $15.16 M(-6.5%) |
| Dec 2012 | $16.21 M(+60.3%) | $16.21 M(-15.2%) |
| Sep 2012 | - | $19.11 M(+217.7%) |
| Jun 2012 | - | $6.02 M(-20.4%) |
| Mar 2012 | - | $7.56 M(-25.3%) |
| Dec 2011 | $10.11 M(-352.3%) | $10.11 M(+86.6%) |
| Sep 2011 | - | $5.42 M(-12.5%) |
| Jun 2011 | - | $6.20 M(+131.9%) |
| Mar 2011 | - | $2.67 M(-166.6%) |
| Dec 2010 | -$4.01 M(+1395.7%) | -$4.01 M(+160.1%) |
| Sep 2010 | - | -$1.54 M(+130.6%) |
| Jun 2010 | - | -$668.40 K(-1683.9%) |
| Mar 2010 | - | $42.20 K(-115.7%) |
| Dec 2009 | -$268.00 K(+262.2%) | -$268.00 K(+183.9%) |
| Sep 2009 | - | -$94.40 K(+5.7%) |
| Jun 2009 | - | -$89.30 K(+5.6%) |
| Mar 2009 | - | -$84.60 K(+14.3%) |
| Dec 2008 | -$74.00 K(+75.8%) | -$74.00 K(+7.4%) |
| Sep 2008 | - | -$68.90 K(+11.5%) |
| Jun 2008 | - | -$61.80 K(+5.6%) |
| Mar 2008 | - | -$58.50 K(+39.0%) |
| Dec 2007 | -$42.10 K(+316.8%) | -$42.10 K(+26.0%) |
| Sep 2007 | - | -$33.40 K(+230.7%) |
| Dec 2006 | -$10.10 K | -$10.10 K |
FAQ
- What is Ampio Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual working capital year-on-year change?
- What is Ampio Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly working capital year-on-year change?
What is Ampio Pharmaceuticals annual working capital?
The current annual working capital of AMPE is $3.36 M
What is the all time high annual working capital for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual working capital is $47.58 M
What is Ampio Pharmaceuticals annual working capital year-on-year change?
Over the past year, AMPE annual working capital has changed by -$8.78 M (-72.32%)
What is Ampio Pharmaceuticals quarterly working capital?
The current quarterly working capital of AMPE is $3.36 M
What is the all time high quarterly working capital for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly working capital is $73.90 M
What is Ampio Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, AMPE quarterly working capital has changed by -$8.78 M (-72.32%)